1-((4-Amino-2-methylpyrimidin-5-yl)methyl)-2-methylpyridin-1-ium chloride hydrochloride

Catalog No. :
ACKNJX734
CAS No. :
13459-77-3
Molecular Formula :
C12H16Cl2N4
Molecular Weight :
287.19

IUPAC Name:1-((4-amino-2-methylpyrimidin-5-yl)methyl)-2-methylpyridin-1-ium chloride hydrochloride

1-((4-Amino-2-methylpyrimidin-5-yl)methyl)-2-methylpyridin-1-ium chloride hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-((4-Amino-2-methylpyrimidin-5-yl)methyl)-2-methylpyridin-1-ium chloride hydrochloride
IUPAC Name1-((4-amino-2-methylpyrimidin-5-yl)methyl)-2-methylpyridin-1-ium chloride hydrochloride
MDL No.MFCD06199300
Molecular FormulaC12H16Cl2N4
Molecular Weight287.19
SMILESCC1=CC=CC=[N+]1CC2=CN=C(C)N=C2N.[H]Cl.[Cl-]
InChI KeyAINXPKWJTYREPA-UHFFFAOYSA-M
Synonym1-((4-AMMONIO-2-METHYL-5-PYRIMIDINYL)METHYL)-2-METHYLPYRIDINIUM DICHLORIDE;<4-Amino-2-methyl-<5>pyrimidylmethyl>-α-methylpyridiniumchlorid-hydrochlorid
CAS No.13459-77-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACKNJX734 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKNJX734 route product structure diagram
    ACKNJX73413459-77-3
Inquiry

2. ACKNJX734 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKNJX734 route product structure diagram
    ACKNJX73413459-77-3
Inquiry

Comments (0)